NORTHROP GRUMMAN CORP /DE/ (NOC) Liabilities and Equity USD 2010 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.
Summary
Northrop Grumman Corp /De/ quarterly Liabilities and Equity history and growth rate from 2010 to 2024.
  • Northrop Grumman Corp /De/ Liabilities and Equity for the quarter ending March 31, 2024 was $47.8 B, a 8.08% increase year-over-year.
Liabilities and Equity, Quarterly (USD)
Liabilities and Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $47.8 B +$3.57 B +8.08% Mar 31, 2024 10-Q 2024-04-25
Q4 2023 $46.5 B +$2.79 B +6.37% Dec 31, 2023 10-Q 2024-04-25
Q3 2023 $44.9 B +$2.16 B +5.06% Sep 30, 2023 10-Q 2023-10-26
Q2 2023 $45.6 B +$3.7 B +8.82% Jun 30, 2023 10-Q 2023-07-27
Q1 2023 $44.2 B +$2.34 B +5.59% Mar 31, 2023 10-Q 2023-04-27
Q4 2022 $43.8 B +$1.18 B +2.76% Dec 31, 2022 10-K 2024-01-25
Q3 2022 $42.7 B +$387 M +0.91% Sep 30, 2022 10-Q 2022-10-27
Q2 2022 $41.9 B -$228 M -0.54% Jun 30, 2022 10-Q 2022-07-28
Q1 2022 $41.9 B +$480 M +1.16% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $42.6 B -$1.89 B -4.25% Dec 31, 2021 10-K 2023-01-26
Q3 2021 $42.3 B -$2.43 B -5.42% Sep 30, 2021 10-Q 2021-10-28
Q2 2021 $42.1 B -$1.33 B -3.07% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 $41.4 B -$1.78 B -4.12% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 $44.5 B +$3.38 B +8.23% Dec 31, 2020 10-K 2022-01-27
Q3 2020 $44.8 B +$4.22 B +10.4% Sep 30, 2020 10-Q 2020-10-22
Q2 2020 $43.5 B +$3.89 B +9.83% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 $43.2 B +$3.45 B +8.68% Mar 31, 2020 10-Q 2020-04-29
Q4 2019 $41.1 B +$3.44 B +9.13% Dec 31, 2019 10-K 2021-01-28
Q3 2019 $40.6 B +$2.61 B +6.88% Sep 30, 2019 10-Q 2019-10-24
Q2 2019 $39.6 B +$2.21 B +5.9% Jun 30, 2019 10-Q 2019-07-24
Q1 2019 $39.8 B +$4.96 B +14.2% Mar 31, 2019 10-Q 2019-04-24
Q4 2018 $37.7 B +$2.53 B +7.19% Dec 31, 2018 8-K 2020-04-29
Q3 2018 $37.9 B +$11.4 B +43.1% Sep 30, 2018 10-Q 2018-10-24
Q2 2018 $37.4 B +$11.6 B +44.8% Jun 30, 2018 10-Q 2018-07-25
Q1 2018 $34.8 B +$9.38 B +36.9% Mar 31, 2018 10-Q 2018-04-25
Q4 2017 $35.1 B +$9.51 B +37.1% Dec 31, 2017 10-K 2019-01-31
Q3 2017 $26.5 B +$2.41 B +10% Sep 30, 2017 10-Q 2017-10-25
Q2 2017 $25.8 B +$1.73 B +7.19% Jun 30, 2017 10-Q 2017-07-26
Q1 2017 $25.4 B +$1.48 B +6.18% Mar 31, 2017 10-Q 2017-04-26
Q4 2016 $25.6 B +$1.19 B +4.87% Dec 31, 2016 10-K 2018-01-29
Q3 2016 $24.1 B +$134 M +0.56% Sep 30, 2016 10-Q 2016-10-26
Q2 2016 $24.1 B -$471 M -1.92% Jun 30, 2016 10-Q 2016-07-27
Q1 2016 $23.9 B -$1.33 B -5.28% Mar 31, 2016 10-Q 2016-04-27
Q4 2015 $24.4 B -$2.15 B -8.08% Dec 31, 2015 10-K 2017-01-30
Q3 2015 $24 B -$1.08 B -4.3% Sep 30, 2015 10-Q 2015-10-28
Q2 2015 $24.6 B -$799 M -3.15% Jun 30, 2015 10-Q 2015-07-29
Q1 2015 $25.3 B -$269 M -1.05% Mar 31, 2015 10-Q 2015-04-29
Q4 2014 $26.6 B +$191 M +0.72% Dec 31, 2014 8-K 2016-04-27
Q3 2014 $25 B -$2.36 B -8.62% Sep 30, 2014 10-Q 2014-10-22
Q2 2014 $25.4 B -$2.16 B -7.84% Jun 30, 2014 10-Q 2014-07-23
Q1 2014 $25.5 B -$379 M -1.46% Mar 31, 2014 10-Q 2014-04-23
Q4 2013 $26.4 B -$162 M -0.61% Dec 31, 2013 10-K 2015-02-02
Q3 2013 $27.4 B +$2.14 B +8.48% Sep 30, 2013 10-Q 2013-10-23
Q2 2013 $27.5 B +$2.28 B +9.05% Jun 30, 2013 10-Q 2013-07-24
Q1 2013 $25.9 B +$861 M +3.44% Mar 31, 2013 10-Q 2013-04-24
Q4 2012 $26.5 B +$1.13 B +4.46% Dec 31, 2012 10-K 2014-02-03
Q3 2012 $25.3 B +$162 M +0.65% Sep 30, 2012 10-Q 2012-10-24
Q2 2012 $25.2 B -$151 M -0.6% Jun 30, 2012 10-Q 2012-07-25
Q1 2012 $25.1 B -$1.74 B -6.48% Mar 31, 2012 10-Q 2012-04-25
Q4 2011 $25.4 B -$6 B -19.1% Dec 31, 2011 10-K 2013-02-05
Q3 2011 $25.1 B -$5.08 B -16.8% Sep 30, 2011 10-Q 2011-10-26
Q2 2011 $25.4 B -$4.32 B -14.5% Jun 30, 2011 10-Q 2011-07-27
Q1 2011 $26.8 B -$2.97 B -9.99% Mar 31, 2011 10-Q 2011-04-27
Q4 2010 $31.4 B Dec 31, 2010 10-K 2012-02-08
Q3 2010 $30.2 B Sep 30, 2010 10-Q 2010-10-27
Q2 2010 $29.7 B Jun 30, 2010 10-Q 2010-07-29
Q1 2010 $29.8 B Mar 31, 2010 10-Q 2010-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.